Abnormal uterine bleeding. Abnormal uterine and vaginal bleeding, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: women with AUB complaint between 25 years to 50 years of age who receive mefenamic acid and tranexamic acid. Lack of autoimmune diseases and cancer, uterine polyps and fibroids over 3 cm lack of excessive bleeding that requires emergency action.
Exclusion criteria
Exclusion criteria: The lack of follow-up treatment. Patients who already have used steroids and hormonal drug. Patients who have been prescribed hormonal drugs initially gynecologist
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 3 months follow up. Method of measurement: VAS questionnaire.;BLEEDING. Timepoint: 3 months follow up. Method of measurement: PBAC questionnaire.;QUALITY OF LIFE. Timepoint: 3 months follow up. Method of measurement: GHQ questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Baqiyatallah university of medical sciences